Classifying kidney problems: can we avoid framing risks as diseases?
- 14 October 2004
- Vol. 329 (7471), 912-915
- https://doi.org/10.1136/bmj.329.7471.912
Abstract
A new international classification system for kidney problems is currently being developed. How can it meet the challenges of avoiding labelling all patients with low function as having kidney disease and being usable in countries with limited resources? Patients with low kidney function may eventually need dialysis or transplantation and can die if these treatments are declined or not available. Early intervention is required to prevent these severe outcomes. Interventions that reduce the rate of loss of kidney function have been shown to be effective in selected patient groups. However, mild to moderate low kidney function is prevalent and often unrecognised in the general population, particularly in elderly people. An internationally accepted classification scheme for kidney problems is needed to facilitate research, clinical management, and the development of health policy. End stage renal disease, defined as kidney function so low that dialysis or transplantation is needed, currently affects 404-1022 people per million population in Europe.1 The burden is large for both patients, whose quality of life and life expectancy are impaired,2 and society because of the high cost of renal replacement therapy.3 Low kidney function refers to abnormalities in clearance of uraemic toxins, often assessed as creatinine clearance or glomerular filtration rate. Low clearance, or low glomerular filtration rate, is commonly known as chronic renal failure. The term chronic renal insufficiency is also widely used; it may have been coined to reduce the apparent severity of this diagnosis. A standard definition does not exist for either term.4 Our understanding of the progression of low glomerular filtration rate derives from observational studies and randomised trials conducted in patients referred for specialist care; these have shown falls in glomerular filtration rate of about 7 to 8 ml/min.5 Until recently it was assumed that all patients with low …This publication has 20 references indexed in Scilit:
- Proteinuria and the risk of developing end-stage renal diseaseKidney International, 2003
- Selling sickness: the pharmaceutical industry and disease mongering * Commentary: Medicalisation of risk factorsBMJ, 2002
- Renal Insufficiency as a Predictor of Cardiovascular Outcomes and the Impact of Ramipril: The HOPE Randomized TrialAnnals of Internal Medicine, 2001
- Clinical outcomes, quality of life, and costs in the North Thames Dialysis Study of elderly people on dialysis: a prospective cohort studyThe Lancet, 2000
- Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuriaThe Lancet, 1999
- Risk factors of end-stage renal disease and serum creatinine in a community-based mass screeningKidney International, 1997
- Risk of developing end-stage renal disease in a cohort of mass screeningKidney International, 1996
- The Effect of Angiotensin-Converting-Enzyme Inhibition on Diabetic NephropathyThe New England Journal of Medicine, 1993
- The prognostic significance of proteinuria: The Framingham studyAmerican Heart Journal, 1984
- Increased Absenteeism from Work after Detection and Labeling of Hypertensive PatientsThe New England Journal of Medicine, 1978